USSTOCK.TODAY
Regular Market
Log in Sign up

AstraZeneca signs AI drug discovery deal with Insitro worth up to $1.5 billion

TIKR +2 ·

AZN Astrazeneca plc
$162.03 +3.99%
View chart & analysis →
  1. 1The drug discovery agreement between AstraZeneca and Insitro is worth up to $1.5 billion.
  2. 2AstraZeneca is currently investing $40 million in cash.
  3. 3AstraZeneca can receive approximately $1.46 billion in development and commercialization milestones.

So what's the key point?

AstraZeneca has entered into an AI drug discovery contract with Insitro worth up to $1.5 billion. The company is spending $40 million now and could receive about $1.46 billion later.

Source TIKR +2 · View original ↗

Related 3-line summaries

AstraZeneca Fails Phase 3 Trial for Rare Bone Disease Treatment Clinical Trials Arena · 2d agoAstraZeneca opens new $1 billion R&D center in Massachusetts Quartz +2 · Oct 6Futu Holdings faces regulatory risks despite high operational efficiency The Motley Fool +1 · 2h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news